Last reviewed · How we verify
NCT07123259
Ulcer Pomegranate Muffins
NA trial testing WHOLE WHEAT MUFFIN in Gastric in 82 participants. Completed in 12 October 2024.
10 October 2024
Quick facts
| Lead sponsor | University of Lahore |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | supportive care |
| Enrollment | 82 |
| Start date | 10 August 2024 |
| Primary completion | 10 October 2024 |
| Estimated completion | 12 October 2024 |
| Sites | 1 location across Pakistan |
Drugs / interventions tested
- WHOLE WHEAT MUFFIN
- 1.5g enriched pomegranate muffins
- 3g enriched pomegranate muffins
Conditions studied
- Gastric — all drugs for Gastric →
- Peptic Ulcer — all drugs for Peptic Ulcer →
Sponsor
University of Lahore
Who can join
Adults 40 to 60, any sex, with Gastric or Peptic Ulcer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Pomegranate (Punica granatum L.) peel powder, known for its potent antioxidant, anti-inflammatory, and antimicrobial properties, has shown promise in the dietary management of gastrointestinal disorders. In recent clinical observations, incorporating pomegranate peel powder into muffins consumed by patients with gastric ulcers demonstrated potential anti-ulcerative colitis activity. The bioactive compounds in the peel, such as polyphenols (punicalagins, ellagic acid), help reduce oxidative stress and modulate inflammatory pathways in the gut. Patients consuming these enriched muffins reported improvements in gastrointestinal symptoms, reduced mucosal inflammation, and enhanced mucosal healing, suggesting a supportive role of pomegranate peel as a functional food ingredient in managing gastric and colitis-related conditions.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07123259
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Gastric
Currently open trials in the same condition.
- NCT07031414 — Preoperative Residual Gastric Volume · active not recruiting
- NCT06696209 — To Evaluate the Best Metric for Inspection Time During a Diagnostic and/or Surveillance Upper Gastrointestinal Endoscopy · NA · recruiting
- NCT05205343 — Trans-Pacific Multicenter Collaborative Study of Minimally Invasive Proximal Versus Total Gastrectomy for Proximal Gastr · recruiting
Other University of Lahore trials
Trials by the same sponsor.
- NCT07420244 — Task-oriented Training Versus Group Circuit Training in Children With Quadriplegic Cerebral Palsy · NA · not yet recruiting
- NCT07446218 — Pharmacist-led Interventions in Psychiatric Patients · NA · not yet recruiting
- NCT07359378 — Progressive Resistance Exercise Versus Functional Training in Elderly With Risk of Fall. · NA · not yet recruiting
- NCT07244913 — Therapeutic Effects of Instrument-assisted Versus Sound-assisted Soft Tissue Mobilization in Chronic Non-specific Low Ba · NA · recruiting
- NCT07436624 — Kabat Rehabilitation Versus Kinesiology Taping in Bell's Palsy · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07123259 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Lahore
- Last refreshed: 19 August 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07123259.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing